Related Experiment Video
Updated: Aug 31, 2025

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
Published on: March 21, 2021
Associations between sarcopenia with asthmatic prevalence, lung function and comorbidity.
Zhigang Hu1,2,3, Yufeng Tian4, Xinyu Song5,6
1Department of Respiratory and Critical Care Medicine, The First College of Clinical Medicine Science, China Three Gorges University, Yichang, 443003, People's Republic of China. hxq910813@163.com.
Sarcopenia, a loss of muscle mass, is linked to increased asthma severity, reduced lung function, and more comorbidities like COPD and depression. It may be a treatable trait in asthma management.
Area of Science:
- Gerontology
- Respiratory Medicine
- Public Health
Background:
- Sarcopenia is recognized as a risk factor for severe asthma, yet research on the asthma-sarcopenia link is limited.
- This study investigates the associations between sarcopenia and asthma prevalence, symptoms, lung function, and comorbidities.
Purpose of the Study:
- To determine the prevalence of sarcopenia in individuals with asthma.
- To examine the relationship between sarcopenia and asthma symptoms, including severe shortness of breath.
- To assess the impact of sarcopenia on lung function (e.g., PEF) and comorbidities in asthma patients.
Main Methods:
- Utilized data from the China Health and Retirement Longitudinal Study (CHARLS) and the Study on global AGEing and adult health (SAGE) in China.
- Included 15,404 individuals from CHARLS and 10,263 from SAGE.
- Employed generalized additive models to assess bidirectional associations and estimate relationships between sarcopenia, asthma, and related factors, defining depression using the Center for Epidemiological Studies-Depression Scale.
Main Results:
- Sarcopenia prevalence was higher in asthmatic individuals compared to non-asthmatics in both cohorts.
- Asthma patients with sarcopenia showed significantly higher rates of severe shortness of breath and airway obstruction, and reduced PEF.
- Sarcopenia was positively associated with chronic obstructive pulmonary disease (COPD) and depression in asthmatic individuals.
Conclusions:
- Sarcopenia is associated with poorer asthma outcomes, including reduced lung function and increased comorbidities.
- The findings suggest sarcopenia plays a role in asthma development and progression.
- Sarcopenia may be considered a potentially treatable trait for managing asthma.
Related Concept Videos
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Asthma-I: Introduction

